Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vopr Onkol ; 30(8): 60-7, 1984.
Artigo em Russo | MEDLINE | ID: mdl-6435311

RESUMO

Patients with esophageal and gastric cancer show a decreased diurnal excretion of DOPA matched by a considerable drop in the urine levels of catecholamines and their main metabolites as compared with healthy subjects. This points to a severe inhibition of synthesis and metabolism of catecholamines at all stages. Tumor process progression is accompanied by an ever-increasing inhibition of sympatho-adrenal system function. Simultaneously, disorders develop in the functioning of the cholinergic structures of the nervous system.


Assuntos
Glândulas Suprarrenais/fisiopatologia , Catecolaminas/urina , Neoplasias Esofágicas/fisiopatologia , Neoplasias Gástricas/fisiopatologia , Sistema Nervoso Simpático/fisiopatologia , Adulto , Colinesterases/sangue , Di-Hidroxifenilalanina/urina , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...